National Cancer Centre Singapore (NCCS) shared a post on LinkedIn:
“Get ready for a day of learning about advancement in renal cancer research! From learning about advances in previously treated advanced RCC to learning about the epigenetic impact of truncal mutations in clear cell renal cell carcinoma, be sure to gain insights into the latest breakthroughs and inventions in renal cancer from leading experts.
What are you waiting for? Come and join us at this one-day symposium!
Sign up here.”
More posts featuring National Cancer Centre Singapore.
